Literature DB >> 1509521

K+ channel openers and 'natural' cardioprotection.

D Escande1, I Cavero.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1509521     DOI： 10.1016/0165-6147(92)90083-i

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  17 in total

Review 1.  K+ channel opening: a new drug principle in cardiovascular medicine.

Authors:  J E Nielsen-Kudsk; S Boesgaard; J Aldershvile
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

Review 2.  ATP-sensitive K+ channels in the kidney.

Authors:  U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.

Authors:  F Perez-Vizcaino; O Casis; R Rodriguez; L A Gomez; J Garcia Rafanell; J Tamargo
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 4.  Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels.

Authors:  I Cavero; Y Djellas; J M Guillon
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

5.  Antiischemic effects of nicorandil during coronary angioplasty in humans.

Authors:  S Saito; T Mizumura; T Takayama; J Honye; T Fukui; T Kamata; M Moriuchi; K Hibiya; Y Tamura; Y Ozawa
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

6.  Time-dependent fading of the activation of KATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes.

Authors:  D Thuringer; I Cavero; E Coraboeuf
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

7.  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.

Authors:  C Heurteaux; I Lauritzen; C Widmann; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

8.  Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.

Authors:  T Ibbotson; G Edwards; A H Weston
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat.

Authors:  J L Challinor-Rogers; T K Hay; G A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

Review 10.  Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.

Authors:  J Frampton; M M Buckley; A Fitton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.